Literature DB >> 3371862

Peripheral autoregulation of thyromimetic activity in man.

F S Keck1, U Loos.   

Abstract

This study describes an extrathyroidal mechanism for regulating serum concentration of triiodothyronine (T3) in thyroxine (T4) deficiency or excess. Serum levels of T3, T4, reverse T3 (rT3), and thyrotropin were determined in two series of athyreotic patients (n = 22 and n = 16, respectively) during various doses of T4 substitution therapy. The patients were followed from the severe hypothyroid state up to the modest hyperthyroid state, induced by stepwise increasing doses of administered T4. The periods of constant T4 replacement doses were 1 week (group I) and 5 weeks (group II), respectively. As serum T4 levels rose from less than 0.5 micrograms/dl to 18.9 micrograms/dl, serum T3 levels showed a curvilinear increase, which was pronounced in the very low T4 range while it was flattened at the higher end of the spectrum of T4 levels. As to rT3, an analogous course did not occur. The different character of the relationships between T4 and its conversion products was further elucidated by calculating the T3/T4 and rT3/T4 ratios. T3/T4 ratio declined fourfold from 43.3.10(-3) in the severe hypothyroid to 11.7.10(-3) in the hyperthyroid range. The results support the hypothesis of a peripheral autoregulation of T4 to T3 conversion which appears to be operative at both ends of the T4 spectrum and which serves to maintain or defend serum T3 levels.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3371862     DOI: 10.1055/s-2007-1010765

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  5 in total

1.  T4 but not T3 administration is associated with increased recurrence of Graves' disease after successful medical therapy.

Authors:  G Mastorakos; A G Doufas; E Mantzos; J Mantzos; D A Koutras
Journal:  J Endocrinol Invest       Date:  2003-10       Impact factor: 4.256

2.  A Longitudinal Study of Thyroid Markers Across Pregnancy and the Risk of Gestational Diabetes.

Authors:  Shristi Rawal; Michael Y Tsai; Stefanie N Hinkle; Yeyi Zhu; Wei Bao; Yuan Lin; Pranati Panuganti; Paul S Albert; Ronald C W Ma; Cuilin Zhang
Journal:  J Clin Endocrinol Metab       Date:  2018-07-01       Impact factor: 5.958

3.  Once weekly thyroxine treatment as a strategy to treat non-compliance.

Authors:  S Rangan; A A Tahrani; A F Macleod; P K Moulik
Journal:  Postgrad Med J       Date:  2007-10       Impact factor: 2.401

4.  Daily versus alternate day thyroxine therapy to maintain euthyroidism in children with congenital hypothyroidism.

Authors:  Devi Dayal; Lokesh Saini; Savita Verma Attri; Baljinder Singh; Anil Kumar Bhalla
Journal:  Int J Endocrinol Metab       Date:  2013-10-01

5.  Cardiac Effects of Thyrotropin Oversuppression with Levothyroxine in Young Women with Differentiated Thyroid Cancer.

Authors:  Kyung-Soon Hong; Jung-Woo Son; Ohk Hyun Ryu; Moon-Gi Choi; Ji Yeon Hong; Seong Jin Lee
Journal:  Int J Endocrinol       Date:  2016-06-23       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.